Universal Pharma

Universal Pharma

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Universal Pharma is a private, revenue-generating services company in the pharmaceutical supply chain, headquartered in London. It does not develop its own therapeutics but instead supplies critical ingredients (APIs, intermediates, nutraceuticals) and provides pharmaceutical sourcing services to the industry. The company's strategy is built on becoming a 'partner of choice' by leveraging its team's commercial and technical expertise to address customer needs around quality, pricing, and continuous supply. Its business model is purely service-based, catering to a global market for generic and specialty pharmaceuticals.

Drug DeliverySmall Molecules

Technology Platform

Integrated pharmaceutical supply chain and regulatory compliance network for sourcing APIs, intermediates, nutraceuticals, and controlled substances.

Opportunities

The growing global demand for generic pharmaceuticals and nutraceuticals drives sustained need for reliable API and ingredient suppliers.
Increased outsourcing of complex sourcing and regulatory dossier preparation by pharmaceutical manufacturers presents a key service expansion opportunity.

Risk Factors

High exposure to global supply chain disruptions and regulatory compliance failures, which could halt operations.
Intense price competition in the generic ingredient market pressures margins, and reliance on a limited number of suppliers or customers creates concentration risk.

Competitive Landscape

Universal Pharma competes with large multinational chemical and pharmaceutical distributors (e.g., Sigma-Aldrich, Thermo Fisher), specialized API suppliers, and regional sourcing agents. Differentiation is achieved through niche expertise in controlled substances, customer-centric service, and regulatory support, rather than scale alone.